Momenta Pharmaceuticals, Inc.
10 clinical trials · Sponsor
◉ Watch Momenta Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis (NCT03896295) | Momenta Pharmaceuticals, Inc. | 2019-08-06 |
| Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients (NCT03866577) | Momenta Pharmaceuticals, Inc. | 2018-12-21 |
Track Momenta Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.